Therapiestrategien beim Multiplen Myelom: die künftige Rolle von Bendamustin
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch |
| Veröffentlicht: |
28. Januar 2013
|
| In: |
Onkologie
Year: 2013, Jahrgang: 36, Heft: Supplement 1, Pages: 19-26 |
| ISSN: | 1423-0240 |
| DOI: | 10.1159/000346107 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000346107 Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/346107 
|
| Verfasserangaben: | Hartmut Goldschmidt, Martin Kropff, Lars-Olof Mügge, Wolfram Pönisch |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1748500945 | ||
| 003 | DE-627 | ||
| 005 | 20220819111003.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210217s2013 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1159/000346107 |2 doi | |
| 035 | |a (DE-627)1748500945 | ||
| 035 | |a (DE-599)KXP1748500945 | ||
| 035 | |a (OCoLC)1341393547 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 245 | 1 | 0 | |a Therapiestrategien beim Multiplen Myelom |b die künftige Rolle von Bendamustin |c Hartmut Goldschmidt, Martin Kropff, Lars-Olof Mügge, Wolfram Pönisch |
| 246 | 1 | |i Abweichender Titel laut Vorlage |a Therapeutic strategies in multiple myeloma | |
| 264 | 1 | |c 28. Januar 2013 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.02.2020 | ||
| 700 | 1 | |a Kropff, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mügge, Lars-Olof |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pönisch, Wolfram |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Onkologie |d Basel : Karger, 1978 |g 36(2013), Supplement 1, Seite 19-26 |h Online-Ressource |w (DE-627)300595417 |w (DE-600)1483097-8 |w (DE-576)105282863 |x 1423-0240 |7 nnas |a Therapiestrategien beim Multiplen Myelom die künftige Rolle von Bendamustin |
| 773 | 1 | 8 | |g volume:36 |g year:2013 |g number:Supplement 1 |g pages:19-26 |g extent:8 |a Therapiestrategien beim Multiplen Myelom die künftige Rolle von Bendamustin |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000346107 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/346107 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210217 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1748500945 |e 3856942025 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["ger"],"titleAlt":[{"title":"Therapeutic strategies in multiple myeloma"}],"person":[{"given":"Hartmut","role":"aut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"family":"Kropff","display":"Kropff, Martin","given":"Martin","role":"aut"},{"given":"Lars-Olof","role":"aut","family":"Mügge","display":"Mügge, Lars-Olof"},{"given":"Wolfram","role":"aut","display":"Pönisch, Wolfram","family":"Pönisch"}],"relHost":[{"language":["ger"],"part":{"extent":"8","volume":"36","issue":"Supplement 1","text":"36(2013), Supplement 1, Seite 19-26","pages":"19-26","year":"2013"},"pubHistory":["1.1978 - 36.2013"],"origin":[{"publisher":"Karger","dateIssuedKey":"1978","dateIssuedDisp":"1978-2013","publisherPlace":"Basel"}],"note":["Gesehen am 15.12.2023"],"title":[{"title":"Onkologie","subtitle":"international journal for cancer research and treatment","title_sort":"Onkologie"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Therapiestrategien beim Multiplen Myelom die künftige Rolle von BendamustinOnkologie","recId":"300595417","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["300595417"],"zdb":["1483097-8"],"issn":["1423-0240"]}}],"recId":"1748500945","name":{"displayForm":["Hartmut Goldschmidt, Martin Kropff, Lars-Olof Mügge, Wolfram Pönisch"]},"physDesc":[{"extent":"8 S."}],"id":{"eki":["1748500945"],"doi":["10.1159/000346107"]},"note":["Gesehen am 17.02.2020"],"origin":[{"dateIssuedDisp":"28. Januar 2013","dateIssuedKey":"2013"}],"title":[{"title":"Therapiestrategien beim Multiplen Myelom","title_sort":"Therapiestrategien beim Multiplen Myelom","subtitle":"die künftige Rolle von Bendamustin"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a GOLDSCHMIDTHERAPIEST2820 | ||